Effect of Sodium Glucose Transporter-2 (SGLT-2) Inhibitors on Liver Fibrosis in Patients With Type2 Diabetes and Chronic Liver Disease (F3 Fibrosis) Using Liver Fibroscan

Condition:   Type2diabetes Intervention:   Sponsors:   Diabetes Foundation, India;   National Diabetes Obesity and Cholesterol Foundation Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials